Literature DB >> 6546969

Down-regulation of glucocorticoid receptors in mouse lymphoma cell variants.

M Danielsen, M R Stallcup.   

Abstract

The mouse thymoma-derived cell line W7 is sensitive to the cytolytic action of glucocorticoids. We have isolated a novel class of cell variant that apparently overcomes its inherent sensitivity to glucocorticoids by reversibly down-regulating the level of glucocorticoid receptors. This phenotype is stable during subcloning in the presence and in the absence of glucocorticoids and is dominant in somatic cell hybrids with wild-type cells. Fusion of this variant with wild-type cells produces hybrids that down-regulate and are less sensitive to glucocorticoids than hybrids of receptor-negative and wild-type cells. This is the first demonstration of a phenotypic change which correlates with down-regulation of the glucocorticoid receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546969      PMCID: PMC368722          DOI: 10.1128/mcb.4.3.449-453.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  18 in total

1.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

2.  Modulation of thyroid hormone nuclear receptor levels by 3,5,3'-triiodo-L-thyronine in GH1 cells. Evidence for two functional components of nuclear-bound receptor and relationship to the induction of growth hormone synthesis.

Authors:  H H Samuels; F Stanley; L E Shapiro
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

3.  Interaction of glucocorticoid receptors from lymphoid cell lines with their nuclear acceptor sites.

Authors:  M Pfahl; T Sandros; S Bourgeois
Journal:  Mol Cell Endocrinol       Date:  1978-04       Impact factor: 4.102

4.  Differentiated functions expressed by cultured mouse lymphoma cells. II. Theta antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line.

Authors:  A W Harris; A D Bankhurst; S Mason; N L Warner
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

5.  Differentiated functions expressed by cultured mouse lymphoma cells. I. Specificity and kinetics of cell responses to corticosteroids.

Authors:  A W Harris
Journal:  Exp Cell Res       Date:  1970-06       Impact factor: 3.905

6.  Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines.

Authors:  S Bourgeois; R F Newby
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

7.  A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells.

Authors:  M L Gefter; D H Margulies; M D Scharff
Journal:  Somatic Cell Genet       Date:  1977-03

8.  Relationship of nuclear estrogen receptor levels to induction of ovalbumin and conalbumin mRNA in chick oviduct.

Authors:  E R Mulvihill; R D Palmiter
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

9.  General features of steroid resistance on lymphoid cell lines.

Authors:  M Pfahl; R J Kelleher; S Bourgeois
Journal:  Mol Cell Endocrinol       Date:  1978-04       Impact factor: 4.102

10.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  17 in total

1.  The promoter and first, untranslated exon of the human glucocorticoid receptor gene are GC rich but lack consensus glucocorticoid receptor element sites.

Authors:  J Zong; J Ashraf; E B Thompson
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

2.  Developmental control of glucocorticoid receptor transcriptional activity in embryonic retina.

Authors:  I Ben-Dror; N Havazelet; L Vardimon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

3.  Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone.

Authors:  S Okret; L Poellinger; Y Dong; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Gamma interferon down-regulates glucocorticoid receptor expression and attenuates hormone action in a human osteosarcoma cell line.

Authors:  L N Song
Journal:  Endocrine       Date:  1995-10       Impact factor: 3.633

5.  Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements.

Authors:  Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

6.  Evidence that glucocorticoid- and cyclic AMP-induced apoptotic pathways in lymphocytes share distal events.

Authors:  D R Dowd; R L Miesfeld
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

7.  DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome, gene 1) selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL-dependent manner.

Authors:  Junguo Zhou; Robert H Oakley; John A Cidlowski
Journal:  Mol Endocrinol       Date:  2008-04-16

8.  Differential regulation by dexamethasone of glucocorticoid receptor messenger RNA concentrations in neuronal cultures derived from fetal rat hypothalamus and cerebral cortex.

Authors:  M C Pepin; S Beaulieu; N Barden
Journal:  Cell Mol Neurobiol       Date:  1990-06       Impact factor: 5.046

Review 9.  Glucocorticoid receptors in human leukemias and related diseases.

Authors:  E B Thompson; J R Smith; S Bourgeois; J M Harmon
Journal:  Klin Wochenschr       Date:  1985-08-01

10.  Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome.

Authors:  S A Gómez; G C Fernández; S Vanzulli; G Dran; C Rubel; T Berki; M A Isturiz; M S Palermo
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.